What is CVE-2022-38094?

CVE-2022-38094 is a high-severity vulnerability in Allied-Telesis Centrecom Ar260s, classified under OS Command Injection. CVSS score: 8.8/10. Published 2022-09-08.

How severe is CVE-2022-38094?

High severity. CVSS v3 base score is 8.8 out of 10.

RCE in Allied-Telesis Centrecom Ar260s

CVE-2022-38094

OS command injection vulnerability in the telnet function of CentreCOM AR260S V2 firmware versions prior to Ver.3.3.7 allows a remote authenticated attacker to execute an arbitrary OS command.

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.015 (72.1th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Allied-telesis Centrecom_ar260s — versions v2
Allied-telesis Centrecom_ar260s_firmware
Allied Telesis K.k. Centrecom Ar260s V2 — versions firmware versions prior to Ver.3.3.7

Weakness classification (CWE)

CWE-78 — OS Command Injection

References

vultures@jpcert.or.jp (x_refsource_MISC, Mitigation, Vendor Advisory)
vultures@jpcert.or.jp (Third Party Advisory, x_refsource_MISC, Mitigation)

Frequently asked questions

What is CVE-2022-38094?: CVE-2022-38094 is a high-severity vulnerability in Allied-Telesis Centrecom Ar260s, classified under OS Command Injection. CVSS score: 8.8/10. Published 2022-09-08.
How severe is CVE-2022-38094?: High severity. CVSS v3 base score is 8.8 out of 10.